biotech / news / / Seeking Alpha
Eli Lilly to buy Ajax Therapeutics for up to $2.3B in cash.
Eli Lilly will acquire Ajax Therapeutics for up to $2.3 billion in cash.
KEY POINTS
- The deal includes an upfront payment plus milestone-based clinical and regulatory payments.
- This acquisition targets Ajax’s biopharmaceutical assets to expand Lilly’s portfolio.
- Milestone payments depend on specified clinical and regulatory achievements.
COMPANIES
Summarized by Newsio from Seeking Alpha. How we summarize →